AbCellera Biologics logo
AbCellera Biologics
ABCL | NASDAQ
Chart Builder DCF Calculator
$11.12
-$0.37 (-3.22%)
At close: Nov 16, 2026, 4:00 PM ET
$11.13
+$0.01 (+0.09%)
After-hours: Nov 16, 2026, 7:53 PM ET

AbCellera Biologics Company Profile

Company profile explained

Company Profile

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.

Key Executives

Name Position
Carl Hansen Chief Executive Officer, President & Chairperson
Andrew Booth Chief Financial Officer
Tryn T. Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer
Veronique Lecault Chief Technology Officer & Director
Adam Clarke Senior Vice President of Discovery
Andrew Knowles Vice President of Operations
Caitlin Webster CIPD Director of Talent Development
Marcie Thiessen Senior Director of Finance & Accounting
Martin Hogan Senior Director of Strategic Finance & IR
Murray McCutcheon Senior Vice President of Partnering
Tiffany Chiu Vice President of Communications

Latest SEC Filings

Date Type Title
Aug 24, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 4 Filing
Aug 14, 2026 4 Filing
Aug 13, 2026 8-K Current Report
Aug 13, 2026 424B5 Filing
Aug 13, 2026 4 Filing
Aug 11, 2026 424B5 Filing
Aug 10, 2026 8-K Current Report
Aug 07, 2026 8-K Current Report
View All SEC Filings ➞
AbCellera Biologics
AbCellera Biologics logo
Country Canada
IPO Date Dec 11, 2020
Industry Biotechnology
Sector Healthcare
Employees 562
CEO Carl Hansen

Contact Details

150 W 4th Ave Vancouver, BC V5Y 1G6 Canada

Stock Details

Ticker Symbol ABCL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001703057
CUSIP Number 00288U106
ISIN Number CA00288U1066
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.